drugset / Trial / NCT02854800
Smoking Cessation & Opioid Dependence Treatment Integration
Phase 2/3
Completed
74 enrolled
West Virginia University
National Institute on Drug Abuse (NIDA) · collabPfizer · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study was to examine the feasibility of integrating a smoking cessation intervention for cigarette smokers enrolled in an outpatient program for opioid dependence. The secondary purpose was to compare treatment effects as a function of phase in the outpatient program: 0-90 days (weekly attendance), 90 days-1 year (biweekly attendance), and more than 1 year (monthly attendance).
Timeline
- Start
- 2016-07-08
- Primary completion
- 2017-04-10
- Completion
- 2017-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 1 mg | — |